van der Valk Eline S, Mohseni Mostafa, Iyer Anand M, van den Hurk Maartje J B, Lengton Robin, Kuckuck Susanne, Wester Vincent L, Leenen Pieter J M, Dik Willem A, Visser Jenny A, Kavousi Maryam, Mirzaian Mina, van den Berg Sjoerd A A, van Rossum Elisabeth F C
Obesity Centre CGG, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2520-2529. doi: 10.1210/clinem/dgae081.
Long-term glucocorticoid levels in scalp hair (HairGCs), including cortisol and the inactive form cortisone, represent the cumulative systemic exposure to glucocorticoids over months. HairGCs have repeatedly shown associations with cardiometabolic and immune parameters, but longitudinal data are lacking.
We investigated 6341 hair samples of participants from the Lifelines cohort study for cortisol and cortisone levels and associated these to incident cardiovascular diseases (CVD) during 5 to 7 years of follow-up. We computed the odds ratio (OR) of HairGC levels for incident CVD via logistic regression, adjusting for classical cardiovascular risk factors, and performed a sensitivity analysis in subcohorts of participants < 60 years and ≥ 60 years of age. We also associated HairGC levels to immune parameters (total leukocytes and subtypes).
Hair cortisone levels (available in n = 4701) were independently associated with incident CVD (P < .001), particularly in younger individuals (multivariate-adjusted OR 4.21, 95% CI 1.91-9.07 per point increase in 10-log cortisone concentration [pg/mg], P < .001). All immune parameters except eosinophils were associated with hair cortisone (all multivariate-adjusted P < .05).
In this large, prospective cohort study, we found that long-term cortisone levels, measured in scalp hair, represent a relevant and significant predictor for future CVD in younger individuals. These results highlight glucocorticoid action as possible treatment target for CVD prevention, where hair glucocorticoid measurements could help identify individuals that may benefit from such treatments.
头皮毛发中的长期糖皮质激素水平(毛发糖皮质激素,HairGCs),包括皮质醇和无活性形式的可的松,代表了数月来全身对糖皮质激素的累积暴露。毛发糖皮质激素已多次显示与心脏代谢和免疫参数有关,但缺乏纵向数据。
我们调查了生命线队列研究中6341名参与者的毛发样本中的皮质醇和可的松水平,并将这些水平与5至7年随访期间的心血管疾病(CVD)发病情况相关联。我们通过逻辑回归计算了新发CVD的毛发糖皮质激素水平的比值比(OR),并对经典心血管危险因素进行了调整,还在年龄<60岁和≥60岁的参与者亚组中进行了敏感性分析。我们还将毛发糖皮质激素水平与免疫参数(总白细胞及其亚型)相关联。
毛发可的松水平(n = 4701)与新发CVD独立相关(P <.001),尤其是在年轻人中(多变量调整后的OR为4.21,每10对数可的松浓度[pg/mg]增加1个单位,95%CI为1.91 - 9.07,P <.001)。除嗜酸性粒细胞外,所有免疫参数均与毛发可的松相关(所有多变量调整后的P <.05)。
在这项大型前瞻性队列研究中,我们发现,通过测量头皮毛发中的长期可的松水平,可以发现其是年轻人未来发生CVD的一个相关且重要的预测指标。这些结果突出了糖皮质激素作用可能是预防CVD的治疗靶点,毛发糖皮质激素测量有助于识别可能从此类治疗中获益的个体。